|   | 
| 
 | 
 | 
 
 General Aspects
General Aspects
The cis/trans isomerisation of a 
peptidyl-prolyl bond leads to a different propagation direction 
 of the polypeptide backbone in each isomer. 
 "The cis/trans isomerisation at the peptide bond 
N-terminal to proline resembles a molecular 
 switch with the following characteristics: 
 1. There are two switch positions, other positions are unstable 
 2. The energy needed to operate the switch is high on the energy scale 
for bio- 
 logical recognition processes. 
 3. Operation of the switch leads to an amplification of an effect at 
the place 
 where the signal arrives. In the case of the proline switch this 
amplification 
 manifests itself chiefly in the form of a mechanical movement, which 
may 
 be the movement of a segment of the protein backbone. 
 4. Isomerisatin catalysts such as the PPIases act as variable 
components for 
 reducing the switch resistant, and in the presents of many switches 
they 
 assure extra selectivity. The switching resistance (rotational 
barriers) is 
 controlled by varying the enzyme concentration and the selection of 
switching 
 elements by means of the enzyme specificy." 
 
 [G. Fischer, Angew. 
Chem. Int. Ed. Engl. 33(1994)1415] 
 
 Peptidyl-prolyl Bonds in Peptides and Proteins
Peptidyl-prolyl Bonds in Peptides and Proteins
The following data on the occurence of cis prolyl bonds in 
proteins were derived from a set 
 of non-redundant protein structures from the Brookhaven PDB. For 
analysing the structural 
 parameters (peptide bond angle omega, secondary structure) the program 
package Iditis 
 (Oxford Molecular, 
Version 2.1, data base 9.0) was used. 
 
The distribution of the peptide bond angle omega
 for peptidyl-prolyl bonds in proteins 
 shows significant peaks at 180 deg. (trans peptide bond) and 0 
deg. (cis peptide bond). 
There are some differences between the data on the cis
 content in Xaa-Pro bonds (Xaa: 
 amino acid N-terminal to proline) derived from different data bases [Stewart 
et al. J.Mol. 
 Biol. 
214(1990)253, McArthur 
& Thornton J.Mol.Biol. 218(1991)397, Iditis 6.0, Iditis 9.0, 
 data from the actual Brookhaven PDB will be added as soon as 
possible]. McArthur and 
 Thornton found three types of peptidyl-prolyl bonds which do not occur 
in cis conformation 
 (Cys, Met, Trp). Stewart et al. showed only Trp-Pro to take no cis
 conformation. From the 
 Iditis 2.1, data base 9.0 data for all amino acids were received. In 
some cases the cis content 
 decreases from 1990 to 1995 (Arg, Leu), in the most cases deviations 
show no regularity. 
 These results teach a careful approach to statistical data derived 
from the Brookhaven 
 PDB. 
Investigations on 'peptidyl-prolyl bonds and 
secondary structure' show, that trans petidyl- 
 prolyl bonds are distributed in all types of secondary structure. Cis
 peptidyl are found pri- 
 marily in bends and turns, suggesting a specific structural role for 
this type of bonding. 
 [Stewart 
et al. J.Mol.Biol. 214(1990)253]. 
From NMR investigations on proline containig peptides results a 
correlation between 
 the cis content of 
peptidyl-prolyl bonds in peptides and proteins [Reimer 
et al. J.Mol.Biol. 
 279(1998)449]. 
 
 
 Peptidyl-prolyl Cis/Trans Isomerases (PPIases)
Peptidyl-prolyl Cis/Trans Isomerases (PPIases) Definition
DefinitionCyclophilins (Cyp) - inhibited by Cyclosporin A (CsA)
FK506 Binding Proteins (FKBP's) - inhibited by FK506
Parvulins 
  
 Cyclophilins in the Brookhaven PDB
Cyclophilins in the Brookhaven PDB| 1ak4 | HUMAN CYCLOPHILIN A BOUND TO THE N-TERMINAL DOMAIN OF HIV-1 CAPSID PROTEIN | 
| 1clh | CYCLOPHILIN (NMR, 12 STRUCTURES) | 
| 1cyn | CYCLOPHILIN B COMPLEXED WITH [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN | 
| 1fgl | CYCLOPHILIN A COMPLEXED WITH A FRAGMENT OF HIV-1 GAG PROTEIN | 
| 1lop | CYCLOPHILIN A COMPLEXED WITH SUCCINYL-ALA-PRO-ALA-P-NITROANILIDE | 
| 1mik | CYCLOPHILIN A | 
| 1oca | HUMAN CYCLOPHILIN A, UNLIGATED, NMR, 20 STRUCTURES | 
| 1rmh | RECOMBINANT CYCLOPHILIN A FROM HUMAN T CELL | 
| 2cpl | CYCLOPHILIN A | 
| 2cyh | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE ALA-PRO | 
| 2rma | CYCLOPHILIN A (E.C.5.2.1.8) COMPLEXED WITH CYCLOSPORIN A | 
| 2rmb | CYCLOPHILIN A (E.C.5.2.1.8) COMPLEXED WITH DIMETHYL-CYCLOSPORIN A | 
| 2rmc | CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN A | 
| 3cyh | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE SER-PRO | 
| 3cys | CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A (NMR, 22 STRUCTURES) | 
| 4cyh | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE HIS-PRO | 
| 5cyh | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE GLY-PRO | 
 FKBP's in the Brookhaven PDB
FKBP's in the Brookhaven PDB| 1bkf | FK506 BINDING PROTEIN FKBP MUTANT R42K/H87V COMPLEX WITHFK506 | 
| 1fap | THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCINE | 
| 1fkb | FK506 BINDING PROTEIN (FKBP) COMPLEX WITH IMMUNOSUPPRESSANT RAPAMYCINE | 
| 1fkf | FK506 BINDING PROTEIN (FKBP) COMPLEX WITH IMMUNOSUPPRESSANT FK506 | 
| 1fkg | FK506 BINDING PROTEIN (FKBP) COMPLEX WITH ROTAMASE INHIBITOR | 
| 1fkh | FK506 BINDING PROTEIN (FKBP) COMPLEX WITH ROTAMASE INHIBITOR | 
| 1fki | FK506 BINDING PROTEIN (FKBP) COMPLEX WITH ROTAMASE INHIBITOR | 
| 1fkj | ATOMIC STRUCTURE OF FKBP12-FK506 | 
| 1fkk | ATOMIC STRUCTURE OF FKBP12, AN IMMUNOPHILIN BINDING PROTEIN | 
| 1fkl | ATOMIC STRUCTURE OF FKBP12-RAPAYMYCIN | 
| 1fkr | FK506 AND RAPAMYCIN-BINDING PROTEIN (FKBP12) (NMR, 20 STRUCTURES) | 
| 1fks | FK506 AND RAPAMYCIN-BINDING PROTEIN (FKBP12) (NMR) | 
| 1fkt | FK506 AND RAPAMYCIN-BINDING PROTEIN (FKBP12) (NMR) | 
| 1nsg | THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12- RAPAMYCINE | 
| 1pbk | HOMOLOGOUS DOMAIN OF HUMAN FKBP25 | 
| 1rot | STRUCTURE OF FKBP59-I, THE N-TERMINAL DOMAIN OF A 59 KDA FK506-BINDING PROTEIN | 
| 1rou | STRUCTURE OF FKBP59-I, THE N-TERMINAL DOMAIN OF A 59 KDA FK506-BINDING PROYEIN | 
| 1tco | TERNARY COMPLEX OF A CALCINEURIN A FRAGMENT, CALCINEURIN B, FKBP12 | 
 Mechanistical Aspects of the Cis/Trans Isomerisation
Mechanistical Aspects of the Cis/Trans Isomerisation
Experimental studies of intramolecular catalysis of amide isomerisation 
in model systems 
 shows an evidence for a hydrogen bond between the side chain and the 
prolyl imide 
 nitrogen in a cis peptidomimetic [Cox et al. J.Am.Chem.Soc. 
119(1997)2307]. 
 MO and force field calculations on proline containing dipeptides 
shows, that the C-ter- 
 minal amide proton interacts favorably with the imide nitrogen of the 
proline moiety. 
 This calculations indicate a cis/trans barrier lowering of 1.4 
kcal/mol due to intramole- 
 cular catalysis [Fischer & Karplus J.Am.Chem.Soc. 116(1994)11931]. 
 Folding experiments and mutagenic analysis of dihydrofolate reductase 
show that the rate 
 limiting step of refolding, the isomerisation of the proline 66 
residue can be intramole- 
 cularly ctalyzed by the side chain of the arginine 44 residue. The 
guanidinium group NH2 
 nitrogen of this residue forms a hydrogen bond to the imide nitrogen 
of the proline 
 residue. 
 Metal ions (Lewis Acids) in small amounts can catalyse the the 
isomerisation of amides. 
 The side chain of substituted prolines acts as a binding site for 
Cu(II) ions to catalyse the 
 prolyl isomerisation [Cox et al. J.Am.Chem.Soc. 118(1996)5332]. 
 The data discussed above indicate a general acid catalysis of the cis/trans
 isomerisation 
 of a peptidyl-prolyl bond (equation 2 in the scheme). 
In the structure of the PPIase cyclophilin compexed with a substrate, 
the guanidinium 
 group of an arginine in the active site can form a hydrogen bond with 
the lone pair 
 electrons of the peptidyl-prolyl bond in the substrate peptide. The 
structure of different 
 complexes of cyclophilin with inihibitors, substrate peptides and 
protein fragments may 
 provide insight into the mechanism of the enzymatic catalysis of the 
prolyl isomerisa- 
 tion. 
1. The cyclophilin-substrate complex:
The first three figures show the recombinant cyclophilin A from human T 
cell (Cyp) 
 complexed with the model peptide Suc-Ala-Ala-Pro-Phe-pNA (AAPF); 
 PDB code: 1rmh 
Figure 1: The Cyp-AAPF complex
Figure 2: The active site (proline binding 
pocket, Conolly surface) 
 of the Cyp-AAPF complex 
 
 Figure 3: The active site (proline binding 
pocket, Conolly surface transparent) 
 of the Cyp-AAPF complex 
 
 The following figures shows the recombinant cyclophilin A from human T 
cell (Cyp) 
 complexed with a fragment of the HIV-1 GAG 
protein (PDB code 1fgl). 
This protein 
 play an essential role in the replication of the 
HIV (movie from the Microbiology Video 
 Library at the Department of 
Microbiology & Immunology, University of Leicester). 
Figure 4: The HIV-1 GAG-fragment - Cyp complex
Figure 5: The active site (proline binding 
pocket, Conolly surface, the fragment 
 of the HIV-1 GAG protein is shown as a yellow colored solid ribbon) 
 of this complex 
 
 Figure 6: The active site (proline binding 
pocket, Conolly surface transparent) 
 of this complex 
 
 The side chain of the substrate proline sits in the hydrophobic pocket 
made up of the side 
 chains of Phe60, Met61, Phe113, Ile122 (red colored region on the 
Conolly surface). The 
 Arg55 residue hydrogen bonds to the lone pair electrons of the amide 
nitrogen. Zhao & Ke 
 [Biochemistry 
35(1996)7356] proposed on the basis of the crystal structure, that 
the hydro- 
 gen bond deconjugates the resonance of the amide bond during 
catalysis. The C-terminal 
 region of the proline interacts with hydrophilic amino acids (Arg55, 
His126, blue colored 
 region on the Conolly surface). These facts provide the mechanism 
shown in equation 2 in 
 the scheme discussed mentioned above. 
 The mutant cyclophilin protein in which the arginine residue is 
replaced by alanine (R55A) 
 shows dramatically lower PPIase activity below 1% of the wild type 
enzyme [Zydowski 
 et al. Protein Science 1(1992)1092]. If the histidine residue in the 
active site is replaced 
 by glutamine (H126Q), the PPIase activity decreases (0.5% of wild type 
activity) [Zydows- 
 ki et al.]. 
 A general acid catalysis of the enzymatic cis/trans
 isomerisation (for cyclophilin) by Arg55 
 is not in conflict with the observed pH independence [Harrison 
& Stein Biochemistry 29 
 (1990)3813]. 
The Arg55 is expected to be protonated at a pH range of 5.5-9.0. 
 
 
2. The position of Arg55 in different complexes 
 [derived from Zhao & Ke ; Biochemistry 
35(1996)7356] 
The structures of the cyclophilin complexed with the dipeptides 
Ala-Pro, Ser-Pro, His-Pro 
 and Gly-Pro (2cyh, 3cyh, 4cyh, 5cyh) 
are very similar to the unligated protein (2cpl). 
The 
 superposition of the amino acids forming the proline binding site from 
uncomplexed cyclo- 
 philin (2cpl) 
and the protein ligated with the Ala-Pro (2cyh) 
dipeptide revealed only small 
 displacements (Fig. 7) 
Figure 7: Superposition of the active sites in 
Cyp and the complex Cyp-AlaPro 
 (2cpl: red, 2cyh: yellow) 
In all complexes the two carboxy-terminal oxygens of the dipeptide form 
hydrogen bonds to 
 the Arg55 (Fig. 8). The position of the Arg55 in the cyclophilin 
complexed with cyclosporin A (2rma) 
is very similar to the structures discussed above (Fig. 9). 
Figure 8: Superposition of all dipeptide-Cyp 
structures 
 (dipeptides [stick] and Arg55 [ball & stick] colored by atoms) 
Figure 9: Superposition of the Cyp-AlaPro (yellow) and the Cyp-cyclosporin A complex (red)
The overall binding of the dipeptides to cyclophilin also closely 
resembles that of the substrate 
 tetrapeptide Suc-AlaAlaProPhe-pNA (AAPF) and the binding region of the 
HIV-1 GAG pro- 
 tein. In these cases, the residue Arg55 form one hydrogen bond to the 
carbonyl oxygen an one to 
 the imide nitrogen atom of the substrate proline (Fig. 10). 
Figure 10: Superposition of the two 
Cyp-substrate structures 
 (Cyp-AAPF yellow, Cyp-HIV-1 GAG protein red) 
 
 In comparision to the dipeptide binding the hydrogen bonding pattern 
of the proline, the orienta- 
 tion of the proline in the proline binding pocket and the conformation 
of the side chain of Arg55 
 is changed (Fig.11). 
Figure 11: Superposition of the Cyp-AAPF (red) 
and the Cyp-AlaPro 
 (yellow, proline is colored by atoms) 
Only in the cyclophilin-substrate structures, the guanidinium group of 
Arg55 interacts via hydro- 
 gen bond with the imide nitrogen of the substrate proline. 
The similarity between the orientation of the active side residues in 
cyclophilin, the cyclophilin- 
 cyclosporin A complex (inhibitor) and the dipeptide complexes imply 
these questions: 
 
"Are dipeptides inhibitors for cyclophilins or do they have a 
different catalytic mechanism from 
 the substrate-petides AAPF and HIV-1 GAG fragment? [Zhao & 
Ke]" 
Which role play the amino acid Arg55 in the catalytic mechanism of this 
enzyme? 
 Which role play the amino acid His126 in the catalytic mechanism of 
this enzyme? 
  
| 
 | 
 |